Platelet monoamine oxidase activity in Down's syndrome

Area of Science:

• Biochemistry
• Genetics
• Neuroscience

Background:

• Down syndrome is a genetic disorder associated with intellectual disability.
• Monoamine oxidase (MAO) enzymes play crucial roles in neurotransmitter metabolism.
• Altered MAO activity has been implicated in various neurological conditions.

Purpose of the Study:

• To investigate platelet monoamine oxidase (MAO) activity in individuals with Down syndrome.
• To compare MAO activity between Down syndrome cases and healthy controls.
• To examine MAO activity using different substrates and across sexes.

Main Methods:

• Platelet-rich plasma was isolated from Down syndrome patients and age-matched controls.
• Monoamine oxidase (MAO) activity was assayed spectrophotometrically.
• Tyramine, tryptamine, and beta-phenethylamine were used as substrates.

Main Results:

• Platelet monoamine oxidase (MAO) activity was significantly lower in Down syndrome cases compared to controls.
• This reduction in MAO activity was observed for all tested substrates (tyramine, tryptamine, beta-phenethylamine).
• The Michaelis-Menten constant (Km) for tryptamine was similar between Down syndrome patients and controls, indicating no change in substrate affinity.

Conclusions:

• Individuals with Down syndrome exhibit significantly reduced platelet monoamine oxidase (MAO) activity.
• This enzymatic difference may contribute to altered neurotransmitter levels in Down syndrome.
• Platelet MAO activity could potentially serve as a biomarker for Down syndrome.